1.1400
+0.0100
+(0.88%)
As of 10:34:51 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-18,455.0000
-23,699.0000
-18,787.0000
-10,951.0000
-7,619.0000
Investing Cash Flow
-1,003.0000
-887.0000
-338.0000
-572.0000
-150.0000
Financing Cash Flow
14,249.0000
133.0000
63,390.0000
11,620.0000
9,187.0000
End Cash Position
20,978.0000
21,992.0000
46,442.0000
2,178.0000
2,081.0000
Income Tax Paid Supplemental Data
3.0000
1.0000
--
1.0000
1.0000
Capital Expenditure
-1,003.0000
-887.0000
-338.0000
-572.0000
-150.0000
Issuance of Capital Stock
13,980.0000
133.0000
16.0000
11,620.0000
8,550.0000
Issuance of Debt
--
--
--
--
637.0000
Free Cash Flow
-19,458.0000
-24,586.0000
-19,125.0000
-11,523.0000
-7,769.0000
12/31/2020 - 11/19/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TERN Terns Pharmaceuticals, Inc.
4.3250
-0.35%
HOOK HOOKIPA Pharma Inc.
1.8113
-4.16%
SCPX Scorpius Holdings, Inc.
0.2798
+16.25%
NXTC NextCure, Inc.
0.7001
+0.55%
XOMA XOMA Royalty Corporation
26.28
-3.03%
VTYX Ventyx Biosciences, Inc.
1.6350
+0.93%
CLRB Cellectar Biosciences, Inc.
0.2761
-3.97%
CLSD Clearside Biomedical, Inc.
1.0100
-1.94%
KPRX Kiora Pharmaceuticals, Inc.
3.4500
-1.15%
FOLD Amicus Therapeutics, Inc.
9.64
+0.96%